Product
iCaspase9-transduced T cells
1 clinical trial
9 indications
Indication
Acute Lymphoblastic LeukemiaIndication
Myelodysplastic SyndromeIndication
Acute Myeloid LeukemiaIndication
Chronic Myelogenous LeukemiaIndication
Non-Hodgkin LymphomaIndication
Hemophagocytic LymphohistiocytosisIndication
Hemophagocytic SyndromeIndication
Epstein-Barr virus infectionIndication
X-linked lymphoproliferative syndromeClinical trial
Administration of Haploidentical Donor T Cells Transduced With the Inducible Caspase-9 Suicide GeneStatus: Active (not recruiting), Estimated PCD: 2029-05-01